{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:59:43Z","timestamp":1773813583677,"version":"3.50.1"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Free Radical Biology and Medicine"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.freeradbiomed.2017.08.024","type":"journal-article","created":{"date-parts":[[2017,9,2]],"date-time":"2017-09-02T03:15:13Z","timestamp":1504322113000},"page":"3-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["Clinical aspects and biomarkers of Alzheimer's disease in Down syndrome"],"prefix":"10.1016","volume":"114","author":[{"given":"Panagiotis","family":"Zis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre","family":"Strydom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.freeradbiomed.2017.08.024_bib1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2559.1988.tb02018.x","article-title":"Alzheimer's disease and Down's syndrome","volume":"13","author":"Mann","year":"1988","journal-title":"Histopathology"},{"issue":"7","key":"10.1016\/j.freeradbiomed.2017.08.024_bib2","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/archneurol.2011.36","article-title":"Using positron emission tomography and Carbon 11-labeled Pittsburgh Compound B to image Brain Fibrillar \u03b2-amyloid in adults with down syndrome: safety, acceptability, and feasibility","volume":"68","author":"Landt","year":"2011","journal-title":"Arch. Neurol."},{"issue":"Pt 9","key":"10.1016\/j.freeradbiomed.2017.08.024_bib3","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1093\/brain\/awu173","article-title":"Cognitive functioning in relation to brain amyloid-\u03b2 in healthy adults with Down syndrome","volume":"137","author":"Hartley","year":"2014","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.freeradbiomed.2017.08.024_bib4","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nrn3983","article-title":"A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome","volume":"16","author":"Wiseman","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"issue":"6","key":"10.1016\/j.freeradbiomed.2017.08.024_bib5","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2017.08.024_bib6","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1741-1130.2010.00253.x","article-title":"Dementia in older adults with intellectual disabilities\u2014epidemiology, presentation, and diagnosis","volume":"7","author":"Strydom","year":"2010","journal-title":"J. Policy Pract. Intellect. Disabil."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2017.08.024_bib7","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ajmg.a.35706","article-title":"Changes in mortality and causes of death in the Swedish Down syndrome population","volume":"161A","author":"Englund","year":"2013","journal-title":"Am. J. Med. Genet. A."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2017.08.024_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/jir.12074","article-title":"A prospective 14-year longitudinal follow-up of dementia in persons with Down syndrome","volume":"58","author":"McCarron","year":"2014","journal-title":"J. Intellect. Disabil. Res."},{"issue":"Pt 10","key":"10.1016\/j.freeradbiomed.2017.08.024_bib9","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-2788.2006.00842.x","article-title":"Dementia and mortality in persons with Down's syndrome","volume":"50","author":"Coppus","year":"2006","journal-title":"J. Intellect. Disabil. Res."},{"issue":"13","key":"10.1016\/j.freeradbiomed.2017.08.024_bib10","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/S1474-4422(16)30193-4","article-title":"Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer's disease: a case series","volume":"15","author":"Ryan","year":"2016","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.freeradbiomed.2017.08.024_bib11","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/gps.502","article-title":"Dementia in people with Down's syndrome","volume":"16","author":"Tyrrell","year":"2001","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"2","key":"10.1016\/j.freeradbiomed.2017.08.024_bib12","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3233\/JAD-2010-1247","article-title":"Early age at menopause is associated with increased risk of dementia and mortality in women with Down syndrome","volume":"19","author":"Coppus","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.freeradbiomed.2017.08.024_bib13","series-title":"ICD-10, The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research","author":"World Health Organization","year":"1993"},{"issue":"1","key":"10.1016\/j.freeradbiomed.2017.08.024_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1017\/S0033291708003334","article-title":"The relationship of dementia prevalence in older adults with intellectual disability (ID) to age and severity of ID","volume":"39","author":"Strydom","year":"2009","journal-title":"Psychol. Med."},{"key":"10.1016\/j.freeradbiomed.2017.08.024_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.12688\/wellcomeopenres.9961.1","article-title":"The LonDownS adult cognitive assessment to study cognitive abilities and decline in Down syndrome","volume":"1","author":"Startin","year":"2016","journal-title":"Wellcome Open Res."},{"issue":"6","key":"10.1016\/j.freeradbiomed.2017.08.024_bib16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.7748\/ns.2016.e10524","article-title":"Best practice in caring for adults with dementia and learning disabilities","volume":"31","author":"Strydom","year":"2016","journal-title":"Nurs. Stand."},{"key":"10.1016\/j.freeradbiomed.2017.08.024_bib17","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1192\/bjp.bp.106.028845","article-title":"Prevalence of dementia in intellectual disability using different diagnostic criteria","volume":"191","author":"Strydom","year":"2007","journal-title":"Br. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.freeradbiomed.2017.08.024_bib18","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/gps.4228","article-title":"Dementia diagnostic criteria in Down syndrome","volume":"30","author":"Sheehan","year":"2015","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"3","key":"10.1016\/j.freeradbiomed.2017.08.024_bib19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/19315864.2016.1185324","article-title":"From DSM to DM-ID","volume":"9","author":"Fletcher","year":"2016","journal-title":"J. Ment. Health Res. Intellect. Disabil."},{"issue":"Pt 3","key":"10.1016\/j.freeradbiomed.2017.08.024_bib20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/brain\/120.3.491","article-title":"Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor","volume":"120","author":"Fox","year":"1997","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.freeradbiomed.2017.08.024_bib21","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s11920-012-0291-x","article-title":"Mild cognitive impairment in older adults","volume":"14","author":"Geda","year":"2012","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.freeradbiomed.2017.08.024_bib22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cortex.2015.07.032","article-title":"Behavioural and psychological symptoms of dementia in Down syndrome: early indicators of clinical Alzheimer's disease?","volume":"73","author":"Dekker","year":"2015","journal-title":"Cortex"},{"issue":"Pt 1","key":"10.1016\/j.freeradbiomed.2017.08.024_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1348\/014466507X230967","article-title":"Executive dysfunction and its association with personality and behaviour changes in the development of Alzheimer's disease in adults with Down syndrome and mild to moderate learning disabilities","volume":"47","author":"Ball","year":"2008","journal-title":"Br. J. Clin. Psychol."},{"issue":"7","key":"10.1016\/j.freeradbiomed.2017.08.024_bib24","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/gps.1545","article-title":"Personality and behaviour changes mark the early stages of Alzheimer's disease in adults with Down's syndrome: findings from a prospective population-based study","volume":"21","author":"Ball","year":"2006","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"Pt 2","key":"10.1016\/j.freeradbiomed.2017.08.024_bib25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1046\/j.1365-2788.2000.00263.x","article-title":"Incidence and course of dementia in people with Down's syndrome: findings from a population-based study","volume":"44","author":"Holland","year":"2000","journal-title":"J. Intellect. Disabil. Res."},{"issue":"Pt 5","key":"10.1016\/j.freeradbiomed.2017.08.024_bib26","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1046\/j.1365-2788.2001.00379.x","article-title":"Neurological changes and emotional functioning in adults with Down Syndrome","volume":"45","author":"Nelson","year":"2001","journal-title":"J. Intellect. Disabil. Res."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2017.08.024_bib27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1352\/0895-8017(1998)103<0040:LCIABI>2.0.CO;2","article-title":"Longitudinal changes in adaptive behavior in adults with Down syndrome: interim findings from a longitudinal study","volume":"103","author":"Prasher","year":"1998","journal-title":"Am. J. Ment. Retard."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2017.08.024_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1352\/0895-8017(2008)113[73:MBRTDS]2.0.CO;2","article-title":"Maladaptive behaviors related to dementia status in adults with Down syndrome","volume":"113","author":"Urv","year":"2008","journal-title":"Am. J. Ment. Retard."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2017.08.024_bib29","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1468-3148.2010.00604.x","article-title":"Behavioural excesses and deficits associated with dementia in adults who have Down syndrome","volume":"24","author":"Oliver","year":"2011","journal-title":"J. Appl. Res. Intellect. Disabil."},{"issue":"Pt 9","key":"10.1016\/j.freeradbiomed.2017.08.024_bib30","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1365-2788.2007.00956.x","article-title":"Symptoms of dementia among adults with Down's syndrome: a qualitative study","volume":"51","author":"Deb","year":"2007","journal-title":"J. Intellect. Disabil. Res."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2017.08.024_bib31","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/WAD.0000000000000132","article-title":"Cognitive profiles on the severe impairment battery are similar in Alzheimer disease and Down syndrome with dementia","volume":"30","author":"Dick","year":"2016","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"Pt 6","key":"10.1016\/j.freeradbiomed.2017.08.024_bib32","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1046\/j.1365-2788.2000.00305.x","article-title":"Sequence of cognitive decline in dementia in adults with Down's syndrome","volume":"44","author":"Devenny","year":"2000","journal-title":"J. Intellect. Disabil. Res."},{"issue":"Pt 3","key":"10.1016\/j.freeradbiomed.2017.08.024_bib33","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1046\/j.1365-2788.2002.00365.x","article-title":"Changes in explicit memory associated with early dementia in adults with Down's syndrome","volume":"46","author":"Krinsky-McHale","year":"2002","journal-title":"J. Intellect. Disabil. Res."},{"key":"10.1016\/j.freeradbiomed.2017.08.024_bib34","article-title":"Personality and behavioural changes do not precede memory problems as possible signs of dementia in ageing people with Down syndrome","author":"Blok","year":"2016","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"3","key":"10.1016\/j.freeradbiomed.2017.08.024_bib35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/YPG.0b013e32835fe426","article-title":"Neurodevelopmental and psychiatric issues in Down's syndrome: assessment and intervention","volume":"23","author":"Vicari","year":"2013","journal-title":"Psychiatr. Genet."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2017.08.024_bib36","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1474-4422(11)70289-7","article-title":"Posterior cortical atrophy","volume":"11","author":"Crutch","year":"2012","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.freeradbiomed.2017.08.024_bib37","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jalz.2016.01.010","article-title":"Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease","volume":"12","author":"Schott","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.freeradbiomed.2017.08.024_bib38","unstructured":"British Psychological Society, Dementia and People with Intellectual Disabilities \u2013 Guidance on the Assessment, Diagnosis, Interventions and Support of People with Intellectual Disabilities Who Develop Dementia, Leicester, 2015."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2017.08.024_bib39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1017\/S0790966700003943","article-title":"A five year follow-up study of dementia in persons with Down's syndrome: early symptoms and patterns of deterioration","volume":"17","author":"Cosgrave","year":"2000","journal-title":"Ir. J. Psychol. Med."},{"issue":"Pt. 6","key":"10.1016\/j.freeradbiomed.2017.08.024_bib40","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2788.2006.00902.x","article-title":"Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology","volume":"51","author":"Margallo-Lana","year":"2007","journal-title":"J. Intellect. Disabil. Res."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2017.08.024_bib41","first-page":"400","article-title":"Prospective study of the prevalence of Alzheimer-type dementia in institutionalized individuals with Down syndrome","volume":"101","author":"Visser","year":"1997","journal-title":"Am. J. Ment. Retard."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2017.08.024_bib42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3233\/JAD-2012-111613","article-title":"Down syndrome and dementia: seizures and cognitive decline","volume":"29","author":"Lott","year":"2012","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2017.08.024_bib43","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.nrl.2014.12.008","article-title":"Myoclonic epilepsy in Down syndrome and Alzheimer disease","volume":"32","author":"Aller-Alvarez","year":"2017","journal-title":"Neurologia"},{"issue":"7","key":"10.1016\/j.freeradbiomed.2017.08.024_bib44","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.seizure.2010.04.008","article-title":"Senile myoclonic epilepsy: delineation of a common condition associated with Alzheimer's disease in Down syndrome","volume":"19","author":"De Simone","year":"2010","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.freeradbiomed.2017.08.024_bib45","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/neur.1996.0017","article-title":"Diffuse plaques in the cerebellum and corpus striatum in Down's syndrome contain amyloid beta protein (A beta) only in the form of A beta 42(43)","volume":"5","author":"Mann","year":"1996","journal-title":"Neurodegeneration"},{"issue":"5","key":"10.1016\/j.freeradbiomed.2017.08.024_bib46","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng0892-345","article-title":"A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid","volume":"1","author":"Mullan","year":"1992","journal-title":"Nat. Genet."},{"key":"10.1016\/j.freeradbiomed.2017.08.024_bib47","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1749-6632.1993.tb23052.x","article-title":"Alzheimer's disease families with amyloid precursor protein mutations","volume":"695","author":"Rossor","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"18","key":"10.1016\/j.freeradbiomed.2017.08.024_bib48","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1093\/hmg\/9.18.2589","article-title":"Nonfibrillar diffuse amyloid deposition due to a gamma(42)-secretase site mutation points to an essential role for N-truncated A beta(42) in Alzheimer's disease","volume":"9","author":"Kumar-Singh","year":"2000","journal-title":"Hum. Mol. Genet."},{"issue":"4959","key":"10.1016\/j.freeradbiomed.2017.08.024_bib49","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1126\/science.1971458","article-title":"Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch)","volume":"248","author":"Van Broeckhoven","year":"1990","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.freeradbiomed.2017.08.024_bib50","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/ng0692-218","article-title":"Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene","volume":"1","author":"Hendriks","year":"1992","journal-title":"Nat. Genet."},{"issue":"10","key":"10.1016\/j.freeradbiomed.2017.08.024_bib51","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1248\/bpb.b15-00466","article-title":"Conformational effects of the A21G Flemish mutation on the aggregation of amyloid \u03b2 peptide","volume":"38","author":"Yagi-Utsumi","year":"2015","journal-title":"Biol. Pharm. Bull."},{"issue":"6","key":"10.1016\/j.freeradbiomed.2017.08.024_bib52","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1212\/01.WNL.0000050140.10044.A8","article-title":"Hemorrhagic stroke associated with the Iowa amyloid precursor protein mutation","volume":"60","author":"Greenberg","year":"2003","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.freeradbiomed.2017.08.024_bib53","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ng1718","article-title":"APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy","volume":"38","author":"Rovelet-Lecrux","year":"2006","journal-title":"Nat. Genet."},{"issue":"Pt 11","key":"10.1016\/j.freeradbiomed.2017.08.024_bib54","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1093\/brain\/awl237","article-title":"Phenotype associated with APP duplication in five families","volume":"129","author":"Cabrejo","year":"2006","journal-title":"Brain"},{"issue":"Pt 11","key":"10.1016\/j.freeradbiomed.2017.08.024_bib55","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1093\/brain\/awl203","article-title":"APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy","volume":"129","author":"Sleegers","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.freeradbiomed.2017.08.024_bib56","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.7819.1","article-title":"Intracerebral haemorrhage in Down syndrome: protected or predisposed?","volume":"5","author":"Buss","year":"2016","journal-title":"F1000Research"},{"issue":"9","key":"10.1016\/j.freeradbiomed.2017.08.024_bib57","doi-asserted-by":"crossref","first-page":"e0137093","DOI":"10.1371\/journal.pone.0137093","article-title":"Risk of major cardiovascular events in people with Down syndrome","volume":"10","author":"Sobey","year":"2015","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.freeradbiomed.2017.08.024_bib58","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease","volume":"6","author":"Blennow","year":"2010","journal-title":"Nat. Rev. Neurol."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2017.08.024_bib59","first-page":"70","article-title":"Body fluid biomarkers in Alzheimer's disease","volume":"3","author":"Lu","year":"2015","journal-title":"Ann. Transl. Med."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2017.08.024_bib60","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3233\/JAD-2010-090249","article-title":"Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of aging","volume":"20","author":"Lui","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.freeradbiomed.2017.08.024_bib61","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3233\/JAD-2010-101335","article-title":"Plasma amyloid-beta as a function of age, level of intellectual disability, and presence of dementia in Down syndrome","volume":"23","author":"Head","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.freeradbiomed.2017.08.024_bib62","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0304-3940(01)01657-3","article-title":"Elevated plasma amyloid beta-peptide 1-42 and onset of dementia in adults with Down syndrome","volume":"301","author":"Schupf","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.freeradbiomed.2017.08.024_bib63","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/gps.2321","article-title":"Plasma beta-amyloid and duration of Alzheimer's disease in adults with Down syndrome","volume":"25","author":"Prasher","year":"2010","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.freeradbiomed.2017.08.024_bib64","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/WAD.0b013e3181aba61e","article-title":"The relationship of plasma Abeta levels to dementia in aging individuals with Down syndrome","volume":"23","author":"Matsuoka","year":"2009","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"9","key":"10.1016\/j.freeradbiomed.2017.08.024_bib65","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.neurobiolaging.2011.08.007","article-title":"Plasma \u03b2 amyloid and the risk of Alzheimer's disease in Down syndrome","volume":"33","author":"Coppus","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"10.1016\/j.freeradbiomed.2017.08.024_bib66","first-page":"693","article-title":"Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues","volume":"64","author":"Shin","year":"1991","journal-title":"Lab. Investig.; J. Tech. Methods Pathol."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2017.08.024_bib67","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/alzrt163","article-title":"Plasma tau levels in Alzheimer's disease","volume":"5","author":"Zetterberg","year":"2013","journal-title":"Alzheimers Res. Ther."},{"issue":"17","key":"10.1016\/j.freeradbiomed.2017.08.024_bib68","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1212\/WNL.0000000000003246","article-title":"Plasma tau in Alzheimer disease","volume":"87","author":"Mattsson","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.freeradbiomed.2017.08.024_bib69","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3389\/fnagi.2016.00316","article-title":"Blood beta-amyloid and Tau in Down syndrome: a comparison with Alzheimer's disease","volume":"8","author":"Lee","year":"2017","journal-title":"Front. Aging Neurosci."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2017.08.024_bib70","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3892\/br.2016.630","article-title":"Role of oxidative stress in Alzheimer's disease","volume":"4","author":"Huang","year":"2016","journal-title":"Biomed. Rep."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2017.08.024_bib71","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pnpbp.2008.10.006","article-title":"Oxidative stress and cognitive ability in adults with Down syndrome","volume":"33","author":"Strydom","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"16","key":"10.1016\/j.freeradbiomed.2017.08.024_bib72","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.lfs.2013.08.017","article-title":"Systemic oxidative stress in children and teenagers with Down syndrome","volume":"93","author":"Garlet","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.freeradbiomed.2017.08.024_bib73","doi-asserted-by":"crossref","first-page":"724904","DOI":"10.1155\/2012\/724904","article-title":"Oxidative stress and Down syndrome: a route toward Alzheimer-Like dementia","volume":"2012","author":"Perluigi","year":"2012","journal-title":"Curr. Gerontol. Geriatr. Res."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2017.08.024_bib74","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pnpbp.2008.10.006","article-title":"Oxidative stress and cognitive ability in adults with Down syndrome","volume":"33","author":"Strydom","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.freeradbiomed.2017.08.024_bib75","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3233\/JAD-2012-120073","article-title":"Oxidative stress and memory decline in adults with Down syndrome: longitudinal study","volume":"31","author":"Zis","year":"2012","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2017.08.024_bib76","first-page":"63","article-title":"Elevated urinary neopterin suggests immune activation in Alzheimer's disease and Down's syndrome","volume":"14","author":"Armstrong","year":"1994","journal-title":"Neurosci. Res. Commun."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2017.08.024_bib77","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/gps.3802","article-title":"Plasma neopterin level as a marker of peripheral immune activation in amnestic mild cognitive impairment and Alzheimer's disease","volume":"28","author":"Parker","year":"2013","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.freeradbiomed.2017.08.024_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exger.2016.01.014","article-title":"No relationship between lipoprotein-associated phospholipase A2, proinflammatory cytokines, and neopterin in Alzheimer's disease","volume":"77","author":"Savas","year":"2016","journal-title":"Exp. Gerontol."},{"issue":"1\u20132","key":"10.1016\/j.freeradbiomed.2017.08.024_bib79","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jns.2006.12.010","article-title":"Increased amyloid beta protein levels in children and adolescents with Down syndrome","volume":"254","author":"Mehta","year":"2007","journal-title":"J. Neurol. Sci."},{"issue":"8","key":"10.1016\/j.freeradbiomed.2017.08.024_bib80","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00702-007-0656-1","article-title":"Plasma amino acids and neopterin in healthy persons with Down's syndrome","volume":"114","author":"Coppus","year":"2007","journal-title":"J. Neural Transm."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2017.08.024_bib81","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jamda.2010.03.004","article-title":"Urine neural thread protein measurements in Alzheimer disease","volume":"12","author":"Youn","year":"2011","journal-title":"J. Am. Med. Dir. Assoc."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2017.08.024_bib82","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1162\/15268740252769709","article-title":"Clinical study of a urinary competitve ELISA for neural thread protein in Alzheimer disease","volume":"2002","author":"Munzar","year":"2002","journal-title":"Neurol. Clin. Neurophysiol."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2017.08.024_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(99)00257-9","article-title":"F(2)-isoprostanes: sensitive and specific non-invasive indices of lipid peroxidation in vivo","volume":"147","author":"Pratic\u00f2","year":"1999","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.freeradbiomed.2017.08.024_bib84","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/1531-8249(200011)48:5<809::AID-ANA19>3.0.CO;2-9","article-title":"Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity","volume":"48","author":"Pratic\u00f2","year":"2000","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.freeradbiomed.2017.08.024_bib85","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.bbalip.2010.01.009","article-title":"The neurobiology of isoprostanes and Alzheimer's disease","volume":"1801","author":"Pratic\u00f2","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.freeradbiomed.2017.08.024_bib86","doi-asserted-by":"crossref","first-page":"e97709","DOI":"10.1371\/journal.pone.0097709","article-title":"Memory decline in Down syndrome and its relationship to iPF2alpha, a urinary marker of oxidative stress","volume":"9","author":"Zis","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.freeradbiomed.2017.08.024_bib87","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.neulet.2016.11.023","article-title":"Cognitive ability in Down syndrome and its relationship to urinary neopterin, a marker of activated cellular immunity","volume":"636","author":"Zis","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.freeradbiomed.2017.08.024_bib88","first-page":"606802","article-title":"CSF biomarkers for Alzheimer's disease diagnosis","volume":"2010","author":"Anoop","year":"2010","journal-title":"Int. J. Alzheimer Dis."},{"key":"10.1016\/j.freeradbiomed.2017.08.024_bib89","first-page":"1","article-title":"Cerebrospinal fluid biomarkers for Alzheimer's disease in Down syndrome","volume":"8","author":"Dekker","year":"2017","journal-title":"Alzheimers Dement."},{"issue":"7","key":"10.1016\/j.freeradbiomed.2017.08.024_bib90","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.freeradbiomed.2017.08.024_bib91","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1212\/WNL.56.7.979","article-title":"CSF tau and Abeta42 levels in patients with Down's syndrome","volume":"56","author":"Tapiola","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.freeradbiomed.2017.08.024_bib92","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s12017-014-8302-1","article-title":"Altered cerebrospinal fluid levels of amyloid \u03b2 and amyloid precursor-like protein 1 peptides in Down's syndrome","volume":"16","author":"Portelius","year":"2014","journal-title":"Neuromol. Med."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2017.08.024_bib93","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13024-016-0131-2","article-title":"Cerebrospinal fluid Presenilin-1 increases at asymptomatic stage in genetically determined Alzheimer's disease","volume":"11","author":"Sogorb-Esteve","year":"2016","journal-title":"Mol. Neurodegener."},{"issue":"6","key":"10.1016\/j.freeradbiomed.2017.08.024_bib94","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1001\/archneur.59.6.972","article-title":"Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease","volume":"59","author":"Pratic\u00f2","year":"2002","journal-title":"Arch. Neurol."},{"issue":"14","key":"10.1016\/j.freeradbiomed.2017.08.024_bib95","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1093\/hmg\/dds142","article-title":"Trisomy for synaptojanin1 in Down syndrome is functionally linked to the enlargement of early endosomes","volume":"21","author":"Cossec","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"7","key":"10.1016\/j.freeradbiomed.2017.08.024_bib96","doi-asserted-by":"crossref","first-page":"e595","DOI":"10.1038\/tp.2015.87","article-title":"Modifications of the endosomal compartment in peripheral blood mononuclear cells and fibroblasts from Alzheimer's disease patients","volume":"5","author":"Corlier","year":"2015","journal-title":"Transl. Psychiatry"}],"container-title":["Free Radical Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584917307402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584917307402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:49:00Z","timestamp":1760204940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891584917307402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":96,"alternative-id":["S0891584917307402"],"URL":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.08.024","relation":{},"ISSN":["0891-5849"],"issn-type":[{"value":"0891-5849","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical aspects and biomarkers of Alzheimer's disease in Down syndrome","name":"articletitle","label":"Article Title"},{"value":"Free Radical Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.08.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2017 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}